Home Visual Field Monitoring for Glaucoma in the COVID Era

  • Research type

    Research Study

  • Full title

    Home Visual Field Monitoring for Glaucoma in the COVID Era

  • IRAS ID

    283443

  • Contact name

    Hari Jayaram

  • Contact email

    h.jayaram@nhs.net

  • Sponsor organisation

    Moorfields Eye Hospital NHS Foundation Trust

  • Duration of Study in the UK

    0 years, 4 months, 1 days

  • Research summary

    Glaucoma is the leading cause of preventable sight loss in the United Kingdom, and is characterised by damage to the optic nerve which leads to gradual loss of patients' field of vision. Measurement of a patient’s visual field is therefore an integral component of glaucoma monitoring. This currently requires patients to travel to a clinic or hospital to have this test performed. Over a half of glaucoma patients at Moorfields Eye Hospital are older than 70 years of age, and are therefore at higher risk from COVID-19. Travel to and from clinics and attendance within a hospital setting, where concerns about social distancing may exist, are a concern for both patients and doctors.

    This project will explore whether visual field testing performed at home by patients on their own computer can be used to help monitor their glaucoma. The study will compare the results of home testing to hospital testing, and see if home visual field tests can be used a safe alternative to hospital attendance.

    If home visual field monitoring is shown to be comparable to hospital-based testing, this will have a huge impact upon how we deliver glaucoma care across the United Kingdom. It has the potential to reduce the need for hospital visits for both stable patients and also those who require closer and more intensive monitoring. This change in practice has the potential to help reduce the COVID-19 risk to an older and more vulnerable population in the new era in which we now work.

  • REC name

    London - Bromley Research Ethics Committee

  • REC reference

    20/HRA/2645

  • Date of REC Opinion

    10 Jun 2020

  • REC opinion

    Further Information Favourable Opinion